These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32978498)

  • 1. Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich's ataxia.
    Weng L; Laboureur L; Wang Q; Guo L; Xu P; Gottlieb L; Lynch DR; Mesaros C; Blair IA
    Sci Rep; 2020 Sep; 10(1):15788. PubMed ID: 32978498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.
    Huang ML; Becker EM; Whitnall M; Suryo Rahmanto Y; Ponka P; Richardson DR
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16381-6. PubMed ID: 19805308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
    Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
    Gomes CM; Santos R
    Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in neurons in Friedreich's ataxia.
    Stepanova A; Magrané J
    Mol Cell Neurosci; 2020 Jan; 102():103419. PubMed ID: 31770591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of frataxin in fission yeast iron metabolism: implications for Friedreich's ataxia.
    Wang Y; Wang Y; Marcus S; Busenlehner LS
    Biochim Biophys Acta; 2014 Oct; 1840(10):3022-33. PubMed ID: 24997422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Friedreich's ataxia.
    Alper G; Narayanan V
    Pediatr Neurol; 2003 May; 28(5):335-41. PubMed ID: 12878293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
    Anzovino A; Lane DJ; Huang ML; Richardson DR
    Br J Pharmacol; 2014 Apr; 171(8):2174-90. PubMed ID: 24138602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Mitochondrial and Cytosolic FXN Isoform Expression on Mitochondrial Dynamics and Metabolism.
    Agrò M; Díaz-Nido J
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia.
    Hayashi G; Shen Y; Pedersen TL; Newman JW; Pook M; Cortopassi G
    Hum Mol Genet; 2014 Dec; 23(25):6838-47. PubMed ID: 25104852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia.
    Whitnall M; Suryo Rahmanto Y; Huang ML; Saletta F; Lok HC; Gutiérrez L; Lázaro FJ; Fleming AJ; St Pierre TG; Mikhael MR; Ponka P; Richardson DR
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20590-5. PubMed ID: 23169664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia.
    Martelli A; Friedman LS; Reutenauer L; Messaddeq N; Perlman SL; Lynch DR; Fedosov K; Schulz JB; Pandolfo M; Puccio H
    Dis Model Mech; 2012 Nov; 5(6):860-9. PubMed ID: 22736457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a structural understanding of Friedreich's ataxia: the solution structure of frataxin.
    Musco G; Stier G; Kolmerer B; Adinolfi S; Martin S; Frenkiel T; Gibson T; Pastore A
    Structure; 2000 Jul; 8(7):695-707. PubMed ID: 10903947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
    Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified mouse model of Friedreich's ataxia with conditional
    Perfitt TL; Huichalaf C; Gooch R; Kuperman A; Ahn Y; Chen X; Ullas S; Hirenallur-Shanthappa D; Zhan Y; Otis D; Whiteley LO; Bulawa C; Martelli A
    Am J Physiol Heart Circ Physiol; 2024 Feb; 326(2):H357-H369. PubMed ID: 38038720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friedreich's ataxia: the vicious circle hypothesis revisited.
    Bayot A; Santos R; Camadro JM; Rustin P
    BMC Med; 2011 Oct; 9():112. PubMed ID: 21985033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
    Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
    Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron metabolism and mitochondrial abnormalities in Friedreich ataxia.
    Pandolfo M
    Blood Cells Mol Dis; 2002; 29(3):536-47; discussion 548-52. PubMed ID: 12547248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's Ataxia.
    Perry CE; Halawani SM; Mukherjee S; Ngaba LV; Lieu M; Lee WD; Davis JG; Adzika GK; Bebenek AN; Bazianos DD; Chen B; Mercado-Ayon E; Flatley LP; Suryawanshi AP; Ho I; Rabinowitz JD; Serai SD; Biko DM; Tamaroff J; DeDio A; Wade K; Lin KY; Livingston DJ; McCormack SE; Lynch DR; Baur JA
    JCI Insight; 2024 Jul; 9(16):. PubMed ID: 39171530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.